Das D - Search Results

1

Antithyroid drug carbimazole and its analogues: synthesis and inhibition of peroxidase-catalyzed iodination of L-tyrosine.

Das D, Roy G, Mugesh G. Das D, et al. J Med Chem. 2008 Nov 27;51(22):7313-7. doi: 10.1021/jm800894m. J Med Chem. 2008. PMID: 18954039

2

HCV NS5B polymerase inhibitors 3: Synthesis and in vitro activity of 3-(1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl)-4-hydroxy-2H-quinolizin-2-one derivatives.

Wang G, Zhang L, Wu X, Das D, Ruhrmund D, Hooi L, Misialek S, Ravi Rajagopalan PT, Buckman BO, Kossen K, Seiwert SD, Beigelman L. Wang G, et al. Among authors: das d. Bioorg Med Chem Lett. 2009 Aug 1;19(15):4484-7. doi: 10.1016/j.bmcl.2009.05.021. Epub 2009 May 9. Bioorg Med Chem Lett. 2009. PMID: 19497737

3

HCV NS5B polymerase inhibitors 2: Synthesis and in vitro activity of (1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl) azolo[1,5-a]pyridine and azolo[1,5-a]pyrimidine derivatives.

Wang G, Lei H, Wang X, Das D, Hong J, Mackinnon CH, Coulter TS, Montalbetti CA, Mears R, Gai X, Bailey SE, Ruhrmund D, Hooi L, Misialek S, Rajagopalan PT, Cheng RK, Barker JJ, Felicetti B, Schönfeld DL, Stoycheva A, Buckman BO, Kossen K, Seiwert SD, Beigelman L. Wang G, et al. Among authors: das d. Bioorg Med Chem Lett. 2009 Aug 1;19(15):4480-3. doi: 10.1016/j.bmcl.2009.05.022. Epub 2009 May 9. Bioorg Med Chem Lett. 2009. PMID: 19500983

4

HCV NS5B polymerase inhibitors 1: Synthesis and in vitro activity of 2-(1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl)-1-hydroxynaphthalene derivatives.

Wang G, He Y, Sun J, Das D, Hu M, Huang J, Ruhrmund D, Hooi L, Misialek S, Ravi Rajagopalan PT, Stoycheva A, Buckman BO, Kossen K, Seiwert SD, Beigelman L. Wang G, et al. Among authors: das d. Bioorg Med Chem Lett. 2009 Aug 1;19(15):4476-9. doi: 10.1016/j.bmcl.2009.05.063. Epub 2009 May 23. Bioorg Med Chem Lett. 2009. PMID: 19502055

5

Recent advances in drug discovery of benzothiadiazine and related analogs as HCV NS5B polymerase inhibitors.

Das D, Hong J, Chen SH, Wang G, Beigelman L, Seiwert SD, Buckman BO. Das D, et al. Bioorg Med Chem. 2011 Aug 15;19(16):4690-703. doi: 10.1016/j.bmc.2011.06.079. Epub 2011 Jul 1. Bioorg Med Chem. 2011. PMID: 21798747 Review.

6

Recent developments of 2-aminothiazoles in medicinal chemistry.

Das D, Sikdar P, Bairagi M. Das D, et al. Eur J Med Chem. 2016 Feb 15;109:89-98. doi: 10.1016/j.ejmech.2015.12.022. Epub 2015 Dec 23. Eur J Med Chem. 2016. PMID: 26771245 Review.

7

Recent Advancement of Direct-acting Antiviral Agents (DAAs) in Hepatitis C Therapy.

Das D, Pandya M. Das D, et al. Mini Rev Med Chem. 2018;18(7):584-596. doi: 10.2174/1389557517666170913111930. Mini Rev Med Chem. 2018. PMID: 28901852 Review.

8

Recent advancements of 4-aminoquinazoline derivatives as kinase inhibitors and their applications in medicinal chemistry.

Das D, Hong J. Das D, et al. Eur J Med Chem. 2019 May 15;170:55-72. doi: 10.1016/j.ejmech.2019.03.004. Epub 2019 Mar 7. Eur J Med Chem. 2019. PMID: 30878832 Review.

9

Discovery of new quinazoline derivatives as irreversible dual EGFR/HER2 inhibitors and their anticancer activities - Part 1.

Das D, Xie L, Wang J, Xu X, Zhang Z, Shi J, Le X, Hong J. Das D, et al. Bioorg Med Chem Lett. 2019 Feb 15;29(4):591-596. doi: 10.1016/j.bmcl.2018.12.056. Epub 2018 Dec 24. Bioorg Med Chem Lett. 2019. PMID: 30600209

10

Design, synthesis of orally bioavailable novel anaplastic lymphoma kinase (ALK) inhibitor diphenylaminopyrimidine analogs and efficacy study on NCI-H2228 xenografts mice model.

Das D, Wang J, Li Y, Shi J, Hong J. Das D, et al. Bioorg Med Chem Lett. 2019 Jun 15;29(12):1514-1517. doi: 10.1016/j.bmcl.2019.04.012. Epub 2019 Apr 8. Bioorg Med Chem Lett. 2019. PMID: 31005443

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results